read about the product. Seems to be strong for its specific field.
Very specific field so not going to change the world, but already with rebates from american insurance agencies and a multi national distribution partner, this seems like it is going places.
I would imagine something like this that can provide data in a new way will be invaluable to doctors- primarily paediatricans who care for children with severe lung complaints.
From my work at hospitals, paediatric medicine is often the most progressive as more money will always be spent caring for an 8 year old vs an 88 year old.
And Childhood asthma is very common.
I had Just a quick read of all announcements (as it looked like today was a day of action), is there anyone on here willing to give a good run down of how they see the company.
Thanks to anyone willing to educate me on the specifics of this company!
KSX Price at posting:
1.8¢ Sentiment: Buy Disclosure: Held